H F. Falkenburg

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

T-cell receptor repertoires against HLA class I-restricted minor histocompatibility antigens are highly diverse with a small subset of public clonotypes.

T-cell receptor repertoires against HLA class I-restricted minor histocompatibility antigens are highly diverse with a small subset of public clonotypes.

Journal: Journal for immunotherapy of cancer

Published: August 02, 2026

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Journal: Journal of ovarian research

Published: February 23, 2026

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Circumventing IFN-γ induced resistance in ovarian cancer with a double-hit: NKG2A knockout of PRAME-TCR expressing NK cells.

Journal: Journal of ovarian research

Published: February 23, 2026

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Journal: Blood

Published: December 09, 2025

Optimal genetic feeder cell-expanded and engineered NK cell products are composed of CD56bright and CD56dim NK cells.

Optimal genetic feeder cell-expanded and engineered NK cell products are composed of CD56bright and CD56dim NK cells.

Journal: Cancer immunology, immunotherapy : CII

Published: October 31, 2025

Transplantation strategy affects the risk of GvHD after prophylactic and preemptive donor lymphocyte infusion.

Transplantation strategy affects the risk of GvHD after prophylactic and preemptive donor lymphocyte infusion.

Journal: Annals of hematology

Published: June 25, 2025

A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.

A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.

Journal: Leukemia

Published: June 14, 2025

Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

Journal: Frontiers in immunology

Published: May 28, 2025

Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia.

Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia.

Journal: Blood

Published: February 04, 2025

TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Journal: Cancer immunology research

Published: January 14, 2025

Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia.

Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia.

Journal: Frontiers in immunology

Published: January 06, 2025

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

Journal: Haematologica

Published: December 06, 2024

Showing 1-12 of 144

Last Updated: 09/26/2026